Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | PRAKASH MEDICOS | 1 | ₹499.80 |
| 2 | Schedule 2 | PRAKASH MEDICOS | 1 | ₹22,958.10 |
| 3 | Schedule 4 | PRAKASH MEDICOS | 2 | ₹11,760 |
| 4 | Schedule 6 | GULAB MEDICOSE | 3 | ₹8,700 |
| 5 | Schedule 7 | VIMA EXPORTS | 3 | ₹2,800 |
Tender Value
₹1.9 L
EMD Value
Exempted
Closing Date
25 Mar 2024, 11:00 amClosed
CFA O7 DRUGS
6166087
GEM/2024/B/4730054
Two Packet Bid
Bethanechol 25mg Tab,Cabergoline 0 Point 5mg Tab,Cyclophosphamide 500mg Inj,Daclatasvir 60 mg Tab,D
21 days
Uttar Pradesh; Lucknow
Item wise evaluation
BOQ
7 documents required · 7 mandatory
1 yrs
₹3
10%
Exempted
25 Mar 2024
5 Mar 2024
25 Mar 2024
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Bethanechol 25mg Tab | 210 | No | DGLPMS | 21 |
| 2 | Cabergoline 0 Point 5mg Tab | 1,485 | No | DGLPMS | 21 |
| 3 | Cyclophosphamide 500mg Inj | 150 | VIAL | DGLPMS | 21 |
| 4 | Daclatasvir 60 mg Tab | 500 | No | DGLPMS | 21 |
| 5 | Desmopressin acetate 0 Point 1 mg Tab | 400 | No | DGLPMS | 21 |
| 6 | Donepezil 10 mg Tab | 3,000 | No | DGLPMS | 21 |
| 7 | Gliclazide XR 60mg plus Metformin XR 500mg Tab | 1,000 | No | DGLPMS | 21 |
| 8 | Hydrocortisone 5 mg Tab | 2,000 | No | DGLPMS | 21 |
| 9 | Imatinib Mesylate 100 mg Cap | 400 | No | DGLPMS | 21 |
| 10 | Isoflurane Bottle of 100ml | 6 | Bott | DGLPMS | 21 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6166087.pdf
GEM_BID
bbqrcfa07_2024-03-04-10-28-21_ec040eed9f4f4cd028c247dc30691db0.pdf
BOQ
boq_item_sample_file_2024-03-04-10-28-21_f183b03613c2f6fb4dfe7229d8fbc9e0.csv
BOQ
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .